Order Article Reprints

Yau CE, Low CE, Ong NY, Rana S, Chew LJR, Tyebally SM, Chai P, Yeo T-C, Chan MY, Lee MX, et al. Non-Vitamin K Antagonist Oral Anticoagulants versus Low Molecular Weight Heparin for Cancer-Related Venous Thromboembolic Events: Individual Patient Data Meta-Analysis. Cancers. 2023; 15(24):5887. https://doi.org/10.3390/cancers15245887

Yau, Chun En, Chen Ee Low, Natasha Yixuan Ong, Sounak Rana, Lucas Jun Rong Chew, Sara Moiz Tyebally, Ping Chai, Tiong-Cheng Yeo, Mark Y. Chan, Matilda Xinwei Lee, and et al. 2023. "Non-Vitamin K Antagonist Oral Anticoagulants versus Low Molecular Weight Heparin for Cancer-Related Venous Thromboembolic Events: Individual Patient Data Meta-Analysis" Cancers 15, no. 24: 5887. https://doi.org/10.3390/cancers15245887

Yau, C. E., Low, C. E., Ong, N. Y., Rana, S., Chew, L. J. R., Tyebally, S. M., Chai, P., Yeo, T.-C., Chan, M. Y., Lee, M. X., Tan, L.-L., Koo, C.-Y., Lee, A. R. Y. B., & Sia, C.-H. (2023). Non-Vitamin K Antagonist Oral Anticoagulants versus Low Molecular Weight Heparin for Cancer-Related Venous Thromboembolic Events: Individual Patient Data Meta-Analysis. Cancers, 15(24), 5887. https://doi.org/10.3390/cancers15245887